Jun 20, 2018
Enterome to Participate in the 2018 Microbiome Movement - Drug Development Summit in Boston
Jun 01, 2018
Enterome to Feature Promising Phase 1 Clinical Data With its Lead Candidate EB8018 for Crohn's Disease at the Digestive Disease Week 2018
Feb 12, 2018
Rebiotix Develops Microbiome Health Index(TM) to Identify Indicators for Microbiome Restoration
Jan 19, 2018
2017 Human Microbiome Applications in IVD and Other Healthcare Areas
Jan 10, 2018
BIOHM Health Spearheads Largest Autism Microbiome Study Ever Conducted
Dec 19, 2017
Vanterra Capital Backs BIOHM Health, A Total Microbiome Company
Dec 11, 2017
Interest Grows in Microbiome-based Healthcare Applications: Report
Oct 16, 2017
New Clinical Data and Microbiome Research from Rebiotix's Phase 2 Program for RBX2660 Highlighted at the World Congress of Gastroenterology at ACG2017
Oct 12, 2017
Rebiotix Announces New RBX2660 Data Including a Novel Microbiome Biomarker Analysis to be Presented at the World Congress of Gastroenterology at ACG2017
Sep 20, 2017
Enterome to Move its Research Laboratories to Genopole, France's First Biocluster
Aug 28, 2017
Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017 - 2030
Aug 24, 2017
Microbiome Therapeutics and Diagnostics Markets, 2030 - Over 170 Microbiome Therapeutics and Close to 25 Microbiome Diagnostics
Jun 07, 2017
Rebiotix Data Presented at ASM Microbe 2017 Show RBX2660 Treated Patients' Clinical Success Correlates with Improved Microbiome Diversity
Jun 01, 2017
Rebiotix's Phase 3-Ready RBX2660 to be Featured in Multiple Posters at ASM Microbe 2017